|
End-of-day quote
Liquidnet
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 02/06/25 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
| 02/06/25 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|---|
Revenues | 662K | 537K | 277K | 656K | 385K | |
Other Revenues, Total | 1 | 2 | 1 | -1 | 1 | |
Total Revenues | 662K | 537K | 277K | 656K | 385K | |
Cost of Goods Sold, Total | 861K | 482K | 333K | 726K | 721K | |
Gross Profit | -199K | 54.8K | -55.13K | -69.95K | -336K | |
Selling General & Admin Expenses, Total | 714K | 663K | 434K | 482K | 467K | |
Depreciation & Amortization - (IS) | 477K | 511K | 249K | 899K | 683K | |
Other Operating Expenses | 10.92K | 374 | -11.99K | -12.95K | -648K | |
Other Operating Expenses, Total | 1.2M | 1.17M | 671K | 1.37M | 501K | |
Operating Income | -1.4M | -1.12M | -726K | -1.44M | -837K | |
Interest Expense, Total | -8.91K | -8.83K | -4.61K | -3.46K | -1.22K | |
Interest And Investment Income | - | - | - | - | - | |
Net Interest Expenses | -8.91K | -8.83K | -4.61K | -3.46K | -1.22K | |
Currency Exchange Gains (Loss) | -27 | 68 | - | - | - | |
Other Non Operating Income (Expenses) | - | - | -2 | 1 | -1 | |
EBT, Excl. Unusual Items | -1.41M | -1.13M | -731K | -1.44M | -839K | |
Gain (Loss) On Sale Of Assets | -30K | -78.03K | 67.37K | 32.06K | 0 | |
Other Unusual Items | 378K | -50.21K | -296K | -559K | -29.47K | |
EBT, Incl. Unusual Items | -1.06M | -1.26M | -960K | -1.97M | -868K | |
Income Tax Expense | -230K | -246K | -157K | -191K | -209K | |
Earnings From Continuing Operations | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income to Company | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income - (IS) | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income to Common Incl Extra Items | -832K | -1.01M | -803K | -1.78M | -659K | |
Net Income to Common Excl. Extra Items | -832K | -1.01M | -803K | -1.78M | -659K | |
Per Share Items | ||||||
Net EPS - Basic | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Basic EPS - Continuing Operations | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Basic Weighted Average Shares Outstanding | 4.06M | 4.06M | 4.06M | 14.78M | 14.98M | |
Net EPS - Diluted | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Diluted EPS - Continuing Operations | -0.21 | -0.25 | -0.2 | -0.12 | -0.04 | |
Diluted Weighted Average Shares Outstanding | 4.06M | 4.06M | 4.06M | 14.78M | 14.98M | |
Normalized Basic EPS | -0.22 | -0.17 | -0.11 | -0.06 | -0.03 | |
Normalized Diluted EPS | -0.22 | -0.17 | -0.11 | -0.06 | -0.03 | |
Supplemental Items | ||||||
EBITDA | -924K | -609K | -477K | -539K | -155K | |
EBITA | -1.4M | -1.12M | -726K | -1.44M | -837K | |
EBIT | -1.4M | -1.12M | -726K | -1.44M | -837K | |
Total Revenues (As Reported) | 645K | 578K | 399K | 596K | 975K | |
Effective Tax Rate - (Ratio) | 21.68 | 19.6 | 16.34 | 9.71 | 24.08 | |
Normalized Net Income | -881K | -705K | -457K | -901K | -524K |
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|---|
Assets | ||||||
Cash And Equivalents | 690K | 78.52K | 56.61K | 126K | 22.87K | |
Total Cash And Short Term Investments | 690K | 78.52K | 56.61K | 126K | 22.87K | |
Accounts Receivable, Total | 75.93K | 60.69K | 70.73K | 61.87K | 24.99K | |
Other Receivables | 365K | 333K | 224K | 292K | 242K | |
Total Receivables | 441K | 394K | 295K | 354K | 267K | |
Inventory | 271K | 518K | 714K | 56.29K | 13.86K | |
Prepaid Expenses | - | 3.14K | 31.41K | 10.72K | 6.58K | |
Other Current Assets, Total | 77.81K | - | - | - | - | |
Total Current Assets | 1.48M | 994K | 1.1M | 547K | 310K | |
Gross Property Plant And Equipment | 552K | 469K | 443K | 302K | 302K | |
Accumulated Depreciation | -307K | -317K | -362K | -176K | -219K | |
Net Property Plant And Equipment | 245K | 152K | 81.2K | 126K | 82.27K | |
Long-term Investments | 16.15K | 7.43K | 9.21K | 9.95K | 9.21K | |
Other Intangibles, Total | 70.49K | 69.62K | 88.74K | 88.01K | 88.01K | |
Deferred Charges Long-Term | 413K | 475K | 357K | - | - | |
Other Long-Term Assets, Total | -1 | - | - | - | - | |
Total Assets | 2.22M | 1.7M | 1.63M | 771K | 489K | |
Liabilities | ||||||
Accounts Payable, Total | 329K | 297K | 197K | 339K | 392K | |
Accrued Expenses, Total | 364K | - | - | 68.19K | 186K | |
Short-term Borrowings | 3.82K | - | 45 | - | - | |
Current Portion of Long-Term Debt | 356K | 1.18M | 2.39M | 166K | 387K | |
Current Income Taxes Payable | - | 263K | 124K | 1.95K | 5.55K | |
Unearned Revenue Current, Total | 41.09K | 46.29K | - | - | - | |
Other Current Liabilities | 3.68K | 2.68K | 52.1K | 884 | 10.23K | |
Total Current Liabilities | 1.1M | 1.79M | 2.76M | 576K | 981K | |
Long-Term Debt | 104K | 546K | 308K | 188K | 160K | |
Unearned Revenue Non Current | - | 1.2K | 3.5K | 4.28K | 4.28K | |
Other Non Current Liabilities | 647K | -1 | - | 1 | -1 | |
Total Liabilities | 1.85M | 2.33M | 3.07M | 768K | 1.15M | |
Common Stock, Total | 2.03M | 2.03M | 2.03M | 2.96M | 2.96M | |
Additional Paid In Capital | 3.94M | 3.94M | 3.94M | 5.01M | 5.01M | |
Retained Earnings | -5.6M | -6.61M | -7.41M | -7.97M | -8.63M | |
Comprehensive Income and Other | 10.58K | 10.58K | 10.58K | 10.58K | 10.58K | |
Total Common Equity | 375K | -636K | -1.44M | 3.14K | -656K | |
Total Equity | 375K | -636K | -1.44M | 3.14K | -656K | |
Total Liabilities And Equity | 2.22M | 1.7M | 1.63M | 771K | 489K | |
Supplemental Items | ||||||
ECS Total Shares Outstanding on Filing Date | 4.06M | 4.06M | 4.06M | 14.78M | 14.78M | |
ECS Total Common Shares Outstanding | 4.06M | 4.06M | 4.06M | 14.78M | 14.78M | |
Book Value / Share | 0.09 | -0.16 | -0.35 | 0 | -0.04 | |
Tangible Book Value | 304K | -705K | -1.53M | -84.87K | -744K | |
Tangible Book Value Per Share | 0.07 | -0.17 | -0.38 | -0.01 | -0.05 | |
Total Debt | 464K | 1.72M | 2.7M | 353K | 547K | |
Net Debt | -226K | 1.65M | 2.64M | 228K | 524K | |
Account Code - Inventory Valuation | 3 | 3 | 3 | 3 | 3 | |
Inventories - Raw Materials, Total | - | - | 508K | 40K | - | |
Inventories - Work In Process, Total | - | - | 186K | - | - | |
Inventories - Finished Goods, Total | - | - | 9.78K | - | - | |
Inventories - Others | - | - | 9.69K | 16.29K | 13.86K | |
Machinery, Total | 408K | 408K | 408K | 251K | 251K | |
Full Time Employees | - | - | - | - | 6 |
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|---|
Supplemental Items | ||||||
Change In Net Working Capital | -148K | 210K | 314K | -656K | -318K |
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) |
|---|---|---|---|---|---|---|
Profitability | ||||||
Return on Assets | -52.45 | -35.7 | -27.25 | -74.79 | -83.06 | |
Return on Total Capital | -198.8 | -72.58 | -38.71 | -111.45 | -423.18 | |
Return On Equity % | 613.97 | 774.02 | 77.39 | 247.6 | 201.92 | |
Return on Common Equity | 613.97 | 774.02 | 77.39 | 247.6 | 201.92 | |
Margin Analysis | ||||||
Gross Profit Margin % | -30.06 | 10.21 | -19.87 | -10.67 | -87.32 | |
SG&A Margin | 107.95 | 123.52 | 156.35 | 73.51 | 121.15 | |
EBITDA Margin % | -139.66 | -113.38 | -171.9 | -82.2 | -40.18 | |
EBITA Margin % | -211.76 | -208.59 | -261.62 | -219.33 | -217.46 | |
EBIT Margin % | -211.76 | -208.59 | -261.62 | -219.33 | -217.46 | |
Income From Continuing Operations Margin % | -125.74 | -188.21 | -289.29 | -271.02 | -171.15 | |
Net Income Margin % | -125.74 | -188.21 | -289.29 | -271.02 | -171.15 | |
Net Avail. For Common Margin % | -125.74 | -188.21 | -289.29 | -271.02 | -171.15 | |
Normalized Net Income Margin | -133.2 | -131.39 | -164.55 | -137.41 | -136.11 | |
Asset Turnover | ||||||
Asset Turnover | 0.4 | 0.27 | 0.17 | 0.55 | 0.61 | |
Fixed Assets Turnover | 2.38 | 2.7 | 2.38 | 6.33 | 3.7 | |
Receivables Turnover (Average Receivables) | 17.37 | 8.17 | 4.22 | 9.89 | 8.87 | |
Inventory Turnover (Average Inventory) | 3.29 | 1.22 | 0.54 | 1.88 | 20.57 | |
Short Term Liquidity | ||||||
Current Ratio | 1.35 | 0.56 | 0.4 | 0.95 | 0.32 | |
Quick Ratio | 1.03 | 0.26 | 0.13 | 0.83 | 0.3 | |
Days Sales Outstanding (Average Receivables) | 21.08 | 44.66 | 86.44 | 36.91 | 41.27 | |
Days Outstanding Inventory (Average Inventory) | 111.14 | 298.69 | 675.83 | 193.65 | 17.79 | |
Average Days Payable Outstanding | 101.11 | 156.73 | 170.56 | 1.43K | 197.08 | |
Cash Conversion Cycle (Average Days) | 31.1 | 186.61 | 591.72 | -1.2K | -138.02 | |
Long Term Solvency | ||||||
Total Debt/Equity | 123.82 | -271.09 | -187.34 | 11.26K | -83.36 | |
Total Debt / Total Capital | 55.32 | 158.45 | 214.49 | 99.12 | -501.09 | |
LT Debt/Equity | 27.81 | -85.9 | -21.39 | 5.98K | -24.43 | |
Long-Term Debt / Total Capital | 12.43 | 50.21 | 24.5 | 52.59 | -146.85 | |
Total Liabilities / Total Assets | 83.15 | 137.46 | 188.11 | 99.59 | 234.02 | |
EBIT / Interest Expense | -157.33 | -126.87 | -157.33 | -415.89 | -684.78 | |
EBITDA / Interest Expense | -103.76 | -68.96 | -103.38 | -155.86 | -126.53 | |
(EBITDA - Capex) / Interest Expense | -103.76 | -68.96 | -103.38 | -155.86 | -126.53 | |
Total Debt / EBITDA | -0.5 | -2.83 | -5.65 | -0.66 | -3.53 | |
Net Debt / EBITDA | 0.24 | -2.7 | -5.53 | -0.42 | -3.39 | |
Total Debt / (EBITDA - Capex) | -0.5 | -2.83 | -5.65 | -0.66 | -3.53 | |
Net Debt / (EBITDA - Capex) | 0.24 | -2.7 | -5.53 | -0.42 | -3.39 | |
Growth Over Prior Year | ||||||
Total Revenues, 1 Yr. Growth % | 5.01K | -18.85 | -48.32 | 136.3 | -41.27 | |
Gross Profit, 1 Yr. Growth % | -69.41 | -127.55 | -200.62 | 26.88 | 380.76 | |
EBITDA, 1 Yr. Growth % | -39.94 | -34.12 | -21.65 | 13 | -71.29 | |
EBITA, 1 Yr. Growth % | -30.65 | -20.07 | -35.18 | 98.11 | -41.77 | |
EBIT, 1 Yr. Growth % | -30.65 | -20.07 | -35.18 | 98.11 | -41.77 | |
Earnings From Cont. Operations, 1 Yr. Growth % | -40.84 | 21.47 | -20.57 | 121.38 | -62.91 | |
Net Income, 1 Yr. Growth % | -40.84 | 21.47 | -20.57 | 121.38 | -62.91 | |
Normalized Net Income, 1 Yr. Growth % | -30.48 | -19.95 | -35.28 | 97.33 | -41.82 | |
Diluted EPS Before Extra, 1 Yr. Growth % | - | 21.47 | -20.57 | -39.24 | -63.39 | |
Accounts Receivable, 1 Yr. Growth % | 27.41K | -14.14 | 16.54 | -12.53 | -59.61 | |
Inventory, 1 Yr. Growth % | 7.73 | 91.13 | 37.77 | -92.11 | -75.39 | |
Net Property, Plant and Equip., 1 Yr. Growth % | -21.25 | -37.95 | -46.67 | 55 | -34.64 | |
Total Assets, 1 Yr. Growth % | 99.36 | -23.67 | -3.82 | -52.78 | -36.51 | |
Tangible Book Value, 1 Yr. Growth % | -143.18 | -331.88 | 116.5 | -94.44 | 776.58 | |
Common Equity, 1 Yr. Growth % | -158.03 | -269.68 | 126.25 | -100.22 | -21K | |
Compound Annual Growth Rate Over Two Years | ||||||
Total Revenues, 2 Yr. CAGR % | - | 544.16 | -35.24 | 10.51 | 17.81 | |
Gross Profit, 2 Yr. CAGR % | - | -70.97 | -47.35 | 12.99 | 146.98 | |
EBITDA, 2 Yr. CAGR % | - | -37.1 | -28.15 | -5.91 | -43.04 | |
EBITA, 2 Yr. CAGR % | - | -25.55 | -28.02 | 13.32 | 7.41 | |
EBIT, 2 Yr. CAGR % | - | -25.55 | -28.02 | 13.32 | 7.41 | |
Earnings From Cont. Operations, 2 Yr. CAGR % | - | -15.23 | -1.77 | 32.61 | -9.39 | |
Net Income, 2 Yr. CAGR % | - | -15.23 | -1.77 | 32.61 | -9.39 | |
Normalized Net Income, 2 Yr. CAGR % | - | -25.4 | -28.02 | 13.01 | 7.15 | |
Diluted EPS Before Extra, 2 Yr. CAGR % | - | - | -1.77 | -30.53 | -52.84 | |
Accounts Receivable, 2 Yr. CAGR % | - | 1.38K | 0.03 | 0.96 | -40.56 | |
Inventory, 2 Yr. CAGR % | - | 43.49 | 62.27 | -67.04 | -86.07 | |
Net Property, Plant and Equip., 2 Yr. CAGR % | - | -30.1 | -42.47 | -9.08 | 0.65 | |
Total Assets, 2 Yr. CAGR % | - | 23.36 | -14.32 | -32.61 | -45.25 | |
Tangible Book Value, 2 Yr. CAGR % | - | 0.07 | 124.06 | -65.31 | -30.21 | |
Common Equity, 2 Yr. CAGR % | - | -0.77 | 95.93 | -92.98 | -32.47 | |
Compound Annual Growth Rate Over Three Years | ||||||
Total Revenues, 3 Yr. CAGR % | - | - | 177.82 | -0.3 | -10.49 | |
Gross Profit, 3 Yr. CAGR % | - | - | -56.07 | -29.41 | 83.09 | |
EBITDA, 3 Yr. CAGR % | - | - | -32.32 | -16.45 | -36.65 | |
EBITA, 3 Yr. CAGR % | - | - | -28.91 | 0.87 | -9.23 | |
EBIT, 3 Yr. CAGR % | - | - | -28.91 | 0.87 | -9.23 | |
Earnings From Cont. Operations, 3 Yr. CAGR % | - | - | -17.05 | 28.78 | -13.28 | |
Net Income, 3 Yr. CAGR % | - | - | -17.05 | 28.78 | -13.28 | |
Normalized Net Income, 3 Yr. CAGR % | - | - | -28.85 | 0.74 | -9.43 | |
Diluted EPS Before Extra, 3 Yr. CAGR % | - | - | - | -16.3 | -43.89 | |
Accounts Receivable, 3 Yr. CAGR % | - | - | 535.19 | -4.35 | -25.61 | |
Inventory, 3 Yr. CAGR % | - | - | 41.56 | -40.78 | -70.09 | |
Net Property, Plant and Equip., 3 Yr. CAGR % | - | - | -36.13 | -19.95 | -18.55 | |
Total Assets, 3 Yr. CAGR % | - | - | 13.54 | -29.75 | -33.94 | |
Tangible Book Value, 3 Yr. CAGR % | - | - | 29.42 | -34.66 | 1.79 | |
Common Equity, 3 Yr. CAGR % | - | - | 30.6 | -79.69 | 1.04 | |
Compound Annual Growth Rate Over Five Years | ||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | - | 97.12 | |
Gross Profit, 5 Yr. CAGR % | - | - | - | - | -12.35 | |
EBITDA, 5 Yr. CAGR % | - | - | - | - | -36.83 | |
EBITA, 5 Yr. CAGR % | - | - | - | - | -16.15 | |
EBIT, 5 Yr. CAGR % | - | - | - | - | -16.15 | |
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | - | -14.06 | |
Net Income, 5 Yr. CAGR % | - | - | - | - | -14.06 | |
Normalized Net Income, 5 Yr. CAGR % | - | - | - | - | -16.19 | |
Accounts Receivable, 5 Yr. CAGR % | - | - | - | - | 146.24 | |
Inventory, 5 Yr. CAGR % | - | - | - | - | -44 | |
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | - | -23.38 | |
Total Assets, 5 Yr. CAGR % | - | - | - | - | -15.19 | |
Tangible Book Value, 5 Yr. CAGR % | - | - | - | - | 1.1 | |
Common Equity, 5 Yr. CAGR % | - | - | - | - | 0.31 |
Sign up!
Select your edition
All financial news and data tailored to specific country editions
